Thus far, according to the outlet, animal trials for the vaccine have proven successful.
Now, the final phase of the trial involves testing the vaccine on humans — which could begin as early as January of 2024.
The so-called “cocaine vaccine” works the same way that similar vaccines for heroin and fentanyl work, and they’re mostly given to high-risk drug users.
This approach to addiction — which aims to cure, rather than regulate — is one that’s a novel approach, but has gained in popularity in recent years.
However, the scientists caution that the so-called “cocaine vaccine” doesn’t work the way Narcan does, in that it will not prevent a cocaine overdose, and neither will it save a user who is in the throes of a cocaine overdose.
The vaccine was originally being developed in the United States, but the trials were halted when the results weren’t considered “strong enough” for additional funding.
It’s unclear whether the vaccine will be administered in one dose, or in several doses.
If the vaccine, ultimately, earns regulatory approval, it will be the first time in modern history that cocaine addiction would be treated using a vaccine.
